Did ABT give us a pig in the poke?....were we given the most unprofitable parts of ABT's balance sheet with ABBV? ....I'm holding on for now but my finger is resting on the SELL button....I would have been better off dumping ABBV the day I inherited it....disgusted!
The combined value of your current ABT related holdings is $69.72 per share, based on todays close. ABBV is considered riskier in that the Humira earnings are key to the future of ABBV. In addition, there was also yet another recall of Synthroid not too long ago.
It's a spin-off with no track record and no real past financials to pore over, hence the mundane performance.